Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells

Clinical trials and studies have shown that postmenopausal women undergoing combination hormone replacement therapy containing estrogen and progestin have an increased risk of breast cancer compared with women taking estrogen or placebo alone. Using animal models, we have previously shown that synth...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yayun, Goyette, Sandy, Hyder, Salman M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511027/
https://www.ncbi.nlm.nih.gov/pubmed/28744156
http://dx.doi.org/10.2147/BCTT.S140265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511027/
https://www.ncbi.nlm.nih.gov/pubmed/28744156
http://dx.doi.org/10.2147/BCTT.S140265

Ejemplares similares